75 results
S-8 POS
RXDX
Prometheus Biosciences Inc
16 Jun 23
Registration of securities for employees (post-effective amendment)
9:12am
BIOSCIENCES, INC. 2021 INCENTIVE AWARD PLAN
PROMETHEUS BIOSCIENCES, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plans)
Kelly E.W. Grez … the Prometheus Biosciences, Inc. 2021 Employee Stock Purchase Plan (the “ESPP”); and
Registration Statement No. 333-270099, filed with the SEC on February
S-8 POS
RXDX
Prometheus Biosciences Inc
16 Jun 23
Registration of securities for employees (post-effective amendment)
9:10am
BIOSCIENCES, INC. 2021 INCENTIVE AWARD PLAN
PROMETHEUS BIOSCIENCES, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plans)
Kelly E.W. Grez … the Prometheus Biosciences, Inc. 2021 Employee Stock Purchase Plan (the “ESPP”); and
Registration Statement No. 333-270099, filed with the SEC on February
8-K
EX-3.1
RXDX
Prometheus Biosciences Inc
16 Jun 23
Completion of Acquisition or Disposition of Assets
8:52am
by any director, officer, employee, agent or stockholder of the Corporation to the Corporation or the Corporation’s stockholders, creditors or other
8-K
EX-3.2
RXDX
Prometheus Biosciences Inc
16 Jun 23
Completion of Acquisition or Disposition of Assets
8:52am
, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise … (including, without limitation, any employee benefit plan) (all such persons being referred to hereafter as an “Indemnitee”), or by reason of any action
DEFM14A
RXDX
Prometheus Biosciences Inc
16 May 23
Proxy related to merger
4:01pm
79 of this proxy statement.
Q:
What will happen to the Prometheus 2021 Employee Stock Purchase Plan?
A:
Except for the offering periods under … Prometheus’ 2021 Employee Stock Purchase Plan (the “ESPP”) that were in effect on April 15, 2023 (the “Final Offering Periods”), no new offering periods
PREM14A
e50xrz41sc65 48x
28 Apr 23
Preliminary proxy related to merger
4:58pm
10-K/A
8bbzg4t
28 Apr 23
Annual report (amended)
4:28pm
10-K/A
EX-10.4
rsoc34o3f gsbl10d
28 Apr 23
Annual report (amended)
4:28pm
DEFA14A
sb9yno6apod9ecltu3
17 Apr 23
Additional proxy soliciting materials
6:17am
8-K
EX-2.1
w8ww4g1wfwq8kuy486
17 Apr 23
Entry into a Material Definitive Agreement
6:13am
8-K
EX-1.1
46ovncyz
9 Dec 22
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock
4:32pm
424B5
thx1ykbh
9 Dec 22
Prospectus supplement for primary offering
4:27pm
424B5
myph dsjj0ukdeazx1w
7 Dec 22
Prospectus supplement for primary offering
4:10pm
S-3ASR
EX-4.5
1qg70n
1 Apr 22
Automatic shelf registration
5:13pm
S-3ASR
k3zpoi4x95s
1 Apr 22
Automatic shelf registration
5:13pm
S-3ASR
EX-1.2
hne2xq3rmo
1 Apr 22
Automatic shelf registration
5:13pm